2006
- 14 August 2006 - Ambrx Receives Additional U.S. Patent Covering ReCODE™ Technology
- 24 July 2006 - Ambrx Secures Additional $3 Million in Series C Financing
- 19 July 2006 - Ambrx Names Kevin L. Eastwood Vice President, Corporate Development
- 05 July 2006 - Ambrx Secures $52 Million in Series C Financing